Rehovot, Israel

Dalit Barkan

This inventor holds 1 USPTO granted patent. Top assignee: Yeda Research and Develpment & Co. Ltd. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dalit Barkan. Retrieved from https://idiyas.com/inventor/dalit-barkan-5g5nmq8o

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dalit Barkan: Innovator in Oncology

Introduction

Dalit Barkan is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of oncology through his innovative research and patents. His work focuses on the use of leptin and leptin-related molecules in cancer treatment.

Latest Patents

Dalit Barkan holds a patent titled "Leptin as an inhibitor of tumor cell proliferation." This patent discloses the potential use of leptin in oncology, highlighting its role in inhibiting tumor cell growth. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Barkan is associated with Yeda Research and Development Company Ltd., where he continues to explore groundbreaking ideas in cancer research. His work has the potential to impact the treatment of various cancers, making him a valuable asset in the field.

Collaborations

Dalit Barkan has collaborated with notable colleagues, including Batya Cohen and Menachem Rubinstein. These partnerships enhance the research environment and foster innovation in their projects.

Conclusion

Dalit Barkan's contributions to oncology through his patent on leptin demonstrate his dedication to improving cancer treatment. His work at Yeda Research and Development Company Ltd. positions him as a key figure in the ongoing fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…